# Bristol-Myers Squibb (BMY) P/E ratio: 13.6× today

URL: https://funkfolio.com/stock/BMY/pe-ratio

> Bristol-Myers Squibb (BMY) P/E ratio is 13.6× today, against 15.6× at the end of fiscal 2025. Its median over 17 fiscal year-ends is 22.1×.

---

## Bristol-Myers Squibb (BMY) P/E ratio

**P/E ratio today:** 13.6× as of Nov 18, 2026, 10:39 AM UTC

Bristol-Myers Squibb (BMY) trades at 13.6× its earnings per share over the last twelve months. At the end of fiscal 2025 (December 31, 2025) its P/E ratio was 15.6×. Today's figure is 12.7% below the fiscal 2025 year-end. Figures as of 18 Nov 2026, 10:39 UTC, from the company's filings with the SEC and Yahoo Finance.

### Key facts

- **P/E ratio today:** 13.6×
- **P/E ratio, fiscal 2025:** 15.6×
- **Highest on record:** 100.5× fiscal 2017
- **Lowest on record:** 4.7× fiscal 2009
- **Fiscal years on record:** 17 2007–2025

Figures as of 18 Nov 2026, 10:39 UTC. Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

### Bristol-Myers Squibb P/E ratio, in more detail

Across the 17 fiscal year-ends on record (2007–2025), the highest was 100.5× in fiscal 2017 and the lowest 4.7× in fiscal 2009. Today's P/E ratio is higher than at 18% of the 17 fiscal year-ends on record; their median is 22.1×.

### P/E ratio at each fiscal year-end

The last point is today's figure; the others are fiscal year-ends.

### Bristol-Myers Squibb P/E ratio, year by year

Bristol-Myers Squibb (BMY) P/E ratio by fiscal year

| Fiscal year | P/E ratio | Change | Year ended | Share price at year-end | Diluted EPS |
| --- | --- | --- | --- | --- | --- |
| Today | 13.6× | — | Nov 18, 2026 | $61.35 | — |
| 2025 | 15.6× | — | Dec 31, 2025 | $53.94 | $3.46 |
| 2024 | — | — | Dec 31, 2024 | $56.56 | -$4.41 |
| 2023 | 13.3× | 45.5% down | Dec 31, 2023 | $51.31 | $3.86 |
| 2022 | 24.4× | 22.0% up | Dec 31, 2022 | $71.95 | $2.95 |
| 2021 | 20.0× | — | Dec 31, 2021 | $62.35 | $3.12 |
| 2020 | — | — | Dec 31, 2020 | $62.03 | -$3.99 |
| 2019 | 31.9× | 84.9% up | Dec 31, 2019 | $64.19 | $2.01 |
| 2018 | 17.3× | 82.8% down | Dec 31, 2018 | $51.98 | $3.01 |
| 2017 | 100.5× | 355.5% up | Dec 31, 2017 | $61.28 | $0.61 |
| 2016 | 22.1× | 70.2% down | Dec 31, 2016 | $58.44 | $2.65 |
| 2015 | 74.0× | 50.4% up | Dec 31, 2015 | $68.79 | $0.93 |
| 2014 | 49.2× | 42.5% up | Dec 31, 2014 | $59.03 | $1.20 |
| 2013 | 34.5× | 22.8% up | Dec 31, 2013 | $53.15 | $1.54 |
| 2012 | 28.1× | 72.2% up | Dec 31, 2012 | $32.59 | $1.16 |
| 2011 | 16.3× | 10.3% up | Dec 31, 2011 | $35.24 | $2.16 |
| 2010 | 14.8× | 212.9% up | Dec 31, 2010 | $26.48 | $1.79 |
| 2009 | 4.7× | 46.7% down | Dec 31, 2009 | $25.25 | $5.34 |
| 2008 | 8.9× | 63.5% down | Dec 31, 2008 | $23.25 | $2.62 |
| 2007 | 24.3× | — | Dec 31, 2007 | $26.52 | $1.09 |

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

### How it is calculated

The P/E ratio is the share price divided by earnings per share: for past years this page divides the closing price for the month each fiscal year ended in by that year's diluted earnings per share, and a year with a loss has no P/E.

### How to read it

It is the number of years of current profit the price pays for — a high figure means investors expect growth, and it is best judged against the company's own history.

### P/E ratio at health care companies of similar size

P/E ratio of Bristol-Myers Squibb and comparable companies

| Company | P/E ratio |
| --- | --- |
| [Vertex Pharmaceuticals VRTX](https://funkfolio.com/stock/VRTX/pe-ratio) | 34.4× |
| Bristol-Myers Squibb BMY | 13.6× |
| [Sanofi SNY](https://funkfolio.com/stock/SNY/pe-ratio) | 23.6× |

Price over the last twelve months' earnings per share, as the market data feed reports it.

### Bristol-Myers Squibb, figure by figure

- [Bristol-Myers Squibb market cap](https://funkfolio.com/stock/BMY/market-cap)
- [Bristol-Myers Squibb revenue](https://funkfolio.com/stock/BMY/revenue)
- [Bristol-Myers Squibb earnings](https://funkfolio.com/stock/BMY/earnings)
- [Bristol-Myers Squibb earnings per share (EPS)](https://funkfolio.com/stock/BMY/eps)
- [Bristol-Myers Squibb P/S ratio](https://funkfolio.com/stock/BMY/ps-ratio)
- [Bristol-Myers Squibb P/B ratio](https://funkfolio.com/stock/BMY/pb-ratio)
- [Bristol-Myers Squibb free cash flow](https://funkfolio.com/stock/BMY/free-cash-flow)
- [Bristol-Myers Squibb operating margin](https://funkfolio.com/stock/BMY/operating-margin)
- [Bristol-Myers Squibb dividend](https://funkfolio.com/stock/BMY/dividend)
- [Bristol-Myers Squibb shares outstanding](https://funkfolio.com/stock/BMY/shares-outstanding)
- [Bristol-Myers Squibb total debt](https://funkfolio.com/stock/BMY/total-debt)
- [Bristol-Myers Squibb cash on hand](https://funkfolio.com/stock/BMY/cash)
- [Bristol-Myers Squibb total assets](https://funkfolio.com/stock/BMY/total-assets)
- [Bristol-Myers Squibb return on equity (ROE)](https://funkfolio.com/stock/BMY/roe)
- [Bristol-Myers Squibb return on invested capital (ROIC)](https://funkfolio.com/stock/BMY/roic)

[Bristol-Myers Squibb (BMY) overview: price, valuation and scorecard](https://funkfolio.com/stock/BMY) [All health care companies by market value](https://funkfolio.com/companies/sector/health-care)

### Bristol-Myers Squibb P/E ratio: questions and answers

**What is Bristol-Myers Squibb's P/E ratio?**

Bristol-Myers Squibb (BMY) trades at 13.6× its earnings per share over the last twelve months. At the end of fiscal 2025 (December 31, 2025) its P/E ratio was 15.6×.

**Is Bristol-Myers Squibb's P/E ratio high or low compared with its own history?**

Today's P/E ratio is higher than at 18% of the 17 fiscal year-ends on record; their median is 22.1×.

**What are the highest and lowest P/E ratio figures on record for Bristol-Myers Squibb?**

Across the 17 fiscal year-ends on record (2007–2025), the highest was 100.5× in fiscal 2017 and the lowest 4.7× in fiscal 2009.

**How is Bristol-Myers Squibb's P/E ratio calculated?**

The P/E ratio is the share price divided by earnings per share: for past years this page divides the closing price for the month each fiscal year ended in by that year's diluted earnings per share, and a year with a loss has no P/E. For Bristol-Myers Squibb it is on record here for 17 fiscal years, 2007 to 2025.

Share prices are Yahoo Finance's monthly closes: a fiscal year-end is paired with the close of the month it falls in, and today's quote may be delayed. Fiscal years are named for the calendar year they end in.

### Learn: P/E ratio

[All stocks guides →](https://funkfolio.com/learn/stocks)

- [P/E ratio explained: what a high or low figure means](https://funkfolio.com/learn/stocks/pe-ratio)

  The price-to-earnings (P/E) ratio is a share's price divided by its earnings per share. A stock at $100 earning $5 a share has a P/E of 20: buyers pay $20 for each dollar of yearly profit. A high P/E usually means the market expects profit to grow; a low one can mean doubt, not a bargain.
- [PEG ratio: P/E adjusted for growth, and its limits](https://funkfolio.com/learn/stocks/peg-ratio)

  The PEG ratio is a stock's P/E divided by its expected yearly earnings growth in percent. A P/E of 20 with 10% expected growth gives a PEG of 2; with 20% growth, a PEG of 1. A PEG near 1 is the traditional rough mark of a fair price, but the growth figure is a forecast and often wrong.
- [Altman Z-score: formula, zones and where it fails](https://funkfolio.com/learn/stocks/altman-z-score)

  The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.

### Cite this page

Funkfolio, “Bristol-Myers Squibb (BMY) P/E ratio”, data as of 18 November 2026. https://funkfolio.com/stock/BMY/pe-ratio

Underlying data: the company's filings with the SEC and Yahoo Finance.
